Država: Sjedinjene Američke Države
Jezik: engleski
Izvor: NLM (National Library of Medicine)
GlaxoSmithKline Biologicals SA
INTRAMUSCULAR
unapproved drug other
AS03- AS03 INJECTION, SOLUTION GLAXOSMITHKLINE BIOLOGICALS SA ---------- SPL UNCLASSIFIED SECTION Health Care Professional and Patient Fact Sheets are not available at this time. PRINCIPAL DISPLAY PANEL NDC 58160-855-19 AS03 ADJUVANT COMPONENT NOTICE: NOT TO BE USED ALONE ONE VIAL OF AS03 ADJUVANT COMPONENT AND ONE VIAL OF ANTIGEN COMPONENT MUST BE COMBINED BEFORE USE. 10 Vials of AS03 Adjuvant Component One vial of AS03 Adjuvant Component must be added to one vial of Antigen Component to form ten 0.5-mL doses of vaccine. RX ONLY Rev. 11/20 504407 AS03 as03 injection, solution GlaxoSmithKline Biologicals SA PRODUCT INFORMATION PRODUCT TYPE VACCINE ITEM CODE (SOURCE) NDC:58160-855 ROUTE OF ADMINISTRATION INTRAMUSCULAR INGREDIENTS INGREDIENT KIND INGREDIENT NAME QUANTITY ADJV SQUALENE (UNII: 7QWM220FJH) ADJV .ALPHA.-TOCOPHEROL, DL- (UNII: 7QWA1RIO01) ADJV POLYSORBATE 80 (UNII: 6OZP39ZG8H) PACKAGING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:58160-855- 19 10 in 1 CARTON 1 NDC:58160-855- 01 2.5 mL in 1 VIAL; Type 0: Not a Combination Product MARKETING INFORMATION MARKETING CATEGORY APPLICATION NUMBER OR MONOGRAPH CITATION MARKETING START DATE MARKETING END DATE Unapproved drug other 11/10/2020 LABELER - GlaxoSmithKline Biologicals SA (372748392) Revised: 1/2024 Pročitajte cijeli dokument